IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Immuneering Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.66+0.07 (+1.95%)
Close on Oct 19, 2026
- Market cap
- $236.79M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Immuneering's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 20, 2026 | Apr 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 6, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 25, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 24, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2025 | Aug 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 21, 2025 | Apr 21, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2025 | Jan 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 12, 2024 | Sep 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 23, 2024 | Apr 23, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2024 | Mar 14, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 1, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 1, 2024 | Mar 1, 2024 | SEC EDGAR |